Vera Bradley에 대한 매도 수량은 투자자에게 Vera Bradley의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Vera Bradley (NASDAQ:VRA) 주식, 공매도 수량 보고

Vera Bradley

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

News

EYEN

FUBO

PAYX

PYCR

TSX:CSO

TSX:TD

TSXV:CSO

VSTO

블록에 신규 등장 TD 은행, 또는 토론토 도미니언 은행(TSX:TD)이 찰스 슈왑에 대한 10.1% 지분 매각을 고려 중이다. 이 매각은 이 캐나다 은행의 미국 자금 세탁 스캔들에 따른 전략적 검토의 일환이다. TD 은행의 신임 CEO인 레이먼드 천(Raymond Chun)이 블룸버그에 이 과정을 확인했다.

딜 디스패치: TD 은행이 찰스 슈왑 지분을 판매할까? 아이노비아, 스마트 쉐어가 시장에

Government

Health Care

Retail Sales

Global

Startups

Small Business

AVGO

DKNG

HOOK

QCOM

SBGI

블록에 신규 등장 베라 브래들리(NASDAQ:VRA)의 매출이 감소했다. 이 핸드백 브랜드의 최대 주주인 Fund 1 Investments LLC는 이에 불만을 나타냈다. 12월 30일 이사회에 보낸 서한에서 공동 창립자인 바바라 브래들리 바엑가르드(Barbara Bradley Baekgaard)의 디자인을 &#34;상징적&#34;이고 &#34;수십 년간 혁신과 파괴의 대명사&#34;라고 언급했다.

딜 디스패치: 베라 브래들리는 명암이 혼재된 핸드백, 모델스의 전 CEO가 파티 시티를 탐색

Vera Bradley Inc

Verasity

Virtus Real Asset Income ETF

The Glimpse Group Inc

Virax Biolabs Group Limited - Ordinary Shares

Virax Biolabs Group Ltd

ViewRay Inc

Small Cap Consumer Research analyst Eric Beder reiterates Vera Bradley (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>) with a Buy and maintains $5.5 price target.

Price Target

Reiteration

Analyst Ratings

Small Cap Consumer Research Reiterates Buy on Vera Bradley, Maintains $5.5 Price Target

Vera Bradley (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $5.75, with a high estimate of $6.00 and a low estimate of $5.50. A negative shift in sentiment is evident as analysts have decreased the average price target by 1.37%. 
<img src="https://www.benzinga.com/files/images/story/2025/1736978440_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Vera Bradley. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$5.50</td>
<td>$5.50</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$5.50</td>
<td>$5.50</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Lowers</td>
<td>Buy</td>
<td>$5.50</td>
<td>$6.00</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$6.00</td>
<td>$6.00</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$6.00</td>
<td>$6.00</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$6.00</td>
<td>$6.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Vera Bradley. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Vera Bradley compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Vera Bradley's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Vera Bradley's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/VRA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Vera Bradley analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know Vera Bradley Better</h2>
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
<h3>Vera Bradley's Financial Performance</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Decline in Revenue: Over the 3 months period, Vera Bradley faced challenges, resulting in a decline of approximately -29.92% in revenue growth as of 31 October, 2024. This signifies a reduction in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -15.89%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Vera Bradley's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -5.47%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -3.47%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Vera Bradley's debt-to-equity ratio is below the industry average at 0.42, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>What Are Analyst Ratings?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Vera Bradley Stock

Vera Bradley To Reduce Costs By ~$20M Annually Commencing With FY26

<h2 class="wp-block-heading">New On The Block</h2>
TD Bank, or Toronto-Dominion Bank (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TD#TSX">TD</a>), will consider selling its 10.1% stake in Charles Schwab Corp. The sale is part of a strategic review stemming from the Canadian bank&#8217;s <a href="https://www.benzinga.com/government/24/10/41271816/td-bank-to-face-3b-penalty-growth-limits-in-us-settlement-over-anti-money-laundering-failures">U.S. money-laundering scandal</a>. 
Incoming TD Bank CEO Raymond Chun confirmed the process to <a href="https://www.bloomberg.com/news/articles/2025-01-07/td-mulling-fate-of-schwab-stake-in-review-incoming-ceo-says?srnd=phx-deals">Bloomberg</a>.
Meanwhile, Eyenovia Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) hired New York-based investment bank Chardan to explore either a reverse merger or sale. The ophthalmic technology company is keen on conserving cash while continuing to develop its <a href="https://www.benzinga.com/general/biotech/24/08/40514648/why-is-eye-disease-focused-eyenovia-stock-trading-higher-on-thursday">Gen-2 Optejet device</a>. 
By cutting spending by 60%, Eyenovia is stretching its financial resources to give itself more time to consider potential opportunities. Whether that turns out to be a deal remains to be seen.
Smart Share Global Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EM#NASDAQ">EM</a>) is also considering buyout offers. So far, only Trustar Capital offered to take the company private at 62 cents per share. That&#8217;s <a href="https://www.benzinga.com/news/small-cap/25/01/42809956/why-is-smart-share-global-stock-surging-premarket-on-monday">a tempting 74.8% premium</a>. 
Smart Share boasted a financial war chest of $440.9 million as of mid-2024.
Lastly, Warburg Pincus is exploring a sale of Boca Raton, Florida-based medical software firm Modernizing Medicine. Reuters reports that the auction could attract bids north of $5 billion.
<h2 class="wp-block-heading">Off The Block</h2>
Revelyst, the former Vista Outdoor Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTO#NYSE">VSTO</a>) unit that includes bicycle-related brands, is officially owned by investment firm Strategic Value Partners as part of a $1.125 billion deal. 
True Religion, the jeans brand that&#8217;s as resilient as its famously chunky stitching, has a new owner. After surviving <a href="https://www.latimes.com/business/story/2020-04-13/true-religion-files-for-bankruptcy-again-as-denims-allure-fades">two bankruptcies</a>, the brand began collecting offers from apparel companies and private equity firms, CNBC <a href="https://www.cnbc.com/2024/02/15/jeans-brand-true-religion-exploring-sale.html">reported</a> last year. Acon Investments, teaming up with a fund led by American Eagle CEO Jay Schottenstein, emerged as a winning bidder.
See Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42913622/dollar-soars-to-27-month-highs-30-year-yields-hit-5-stocks-tumble-jobs-report-oil-spike-darken-feds-interest-rate-cut-hopes">Dollar Soars To 27-Month Highs, 30-Year Yields Hit 5%, Stocks Tumble As Jobs Report, Oil Spike Darken Fed&#8217;s Interest Rate Cut Hopes</a>
<h2 class="wp-block-heading">Updates From The Block</h2>
Houston-based gas power producer Calpine received a $30-billion offer from Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>), a nuclear power giant known for its &#8220;emissions-free&#8221; messaging. The deal marks a significant pivot for Constellation, which spun off from Exelon in 2022 and has since doubled its share price. Calpine, previously taken private in 2018 for $17 billion by Energy Capital Partners, Access Industries and CPP Investments, would bring a major gas-fired portfolio under Constellation&#8217;s umbrella, forcing a rethinking of its <a href="https://www.benzinga.com/topic/green-energy">green-energy branding</a>.
Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) and Fubotv Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) have agreed to merge their <a href="https://www.benzinga.com/general/entertainment/25/01/42857294/fubo-gets-fairy-tale-outcome-analyst-says-disney-deal-lowers-risks-overhang-on-stock">live TV streaming businesses</a>. Disney will take a 70% ownership stake in Fubo and the combined entity will become the second-largest live TV streamer in North America, with 6.2 million subscribers — trailing YouTube TV. Hulu + Live TV is included in the deal, while the rest of Hulu remains independent. As part of the agreement, Fubo <a href="https://www.benzinga.com/markets/equities/24/09/40855153/fubotvs-lawsuit-against-disney-fox-and-warner-scheduled-for-october-2025-trial-report">will drop its lawsuit</a> against Disney-backed Venu Sports. Disney and its partners will pay Fubo $220 million and Disney will provide a $145 million term loan due in 2026. The deal also includes a $130 million termination fee if it fails to close due to regulatory issues.
KKR &amp; Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) is extending its offer period to FUJI SOFT shareholders from Jan. 9 to Jan. 24, seemingly hoping patience will outlast Bain Capital's aggressive courtship. Bain Capital, meanwhile, has gone full &#8220;hostile partial takeover&#8221; mode. But KKR, as the largest shareholder, is reportedly confident that Bain Capital's offer <a href="https://www.benzinga.com/25/01/42894417/kkr-extends-tender-offer-for-fuji-soft-amid-bain-capitals-hostile-bid">will not gain traction</a>.
Paychex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) is acquiring Paycor HCM, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYCR#NASDAQ">PYCR</a>) in an all-cash deal valued at $4.1 billion, offering $22.50 per share — a 19% premium over Paycor's recent trading average. The acquisition, unanimously approved by both companies&#8217; boards, is set to close in the first half of 2025, <a href="https://www.benzinga.com/25/01/42855388/paychex-buys-paycor-41-billion-deal-to-strengthen-ai-driven-hr-solutions">pending regulatory approvals</a>.
The Goodyear Tire &amp; Rubber Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GT#NASDAQ">GT</a>) entered <a href="https://www.benzinga.com/25/01/42873285/goodyear-sells-dunlop-brand-to-sumitomo-rubber-expects-65-million-annual-soi-impact">a deal to sell its Dunlop brand</a> to Sumitomo Rubber Industries (SRI) for cash <a href="https://www.benzinga.com/pressreleases/25/01/n42865505/goodyear-announces-sale-of-dunlop-brand-to-sumitomo-rubber-industries" target="_blank" rel="noreferrer noopener">proceeds of around $701 million</a>. The purchase amount covers the brand transfer across Europe, North America and Oceania, a transition support fee and Dunlop tire inventory purchase. The deal also includes ongoing offtake, licensing and other commercial arrangements. Dunlop brand includes trademarks and related intangible assets for consumer, commercial and specialty tires across Europe, North America and Oceania. As per the deal, Goodyear will continue producing and distributing Dunlop consumer tires in Europe until at least Dec. 31, 2025, paying royalties to SRI while retaining all profits.
Italy&#8217;s Banca Ifis on Wednesday made a 298 million euro ($309 million) offer in shares and cash for its competitor, specialty lender Illimity Bank S.p.A. 
<h2 class="wp-block-heading">Bankruptcy Block</h2>
Prospect Medical Holdings is working with law firm Sidley Austin and consulting firm Alvarez &amp; Marsal to restructure three Connecticut hospitals that are under financial strain, according <a href="https://www.wsj.com/articles/prospect-medical-explores-restructuring-56ab7a48" target="_blank" rel="noreferrer noopener">to</a> The Wall Street Journal. Prospect purchased the hospitals (located in Waterbury, Manchester and Vernon) in 2016. Yale New Haven Health System intended to buy the hospitals for $435 million in 2022, but an agreement never came to fruition. As of Friday, the hospitals have not yet filed for bankruptcy.
Corsa Coal Corp. (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/CSO#TSXV">CSO</a>) filed for voluntary chapter 11 relief in the U.S. Bankruptcy Court for the Western District of Pennsylvania on Jan. 6. It intends to conduct a sale of its assets. The company committed $15 million in debtor-in-possession financing to support operations during the bankruptcy and sale process.
<h2 class="wp-block-heading">Notes From The Block</h2>
<ul>
<li>At least 686 U.S. companies filed for bankruptcy in 2024, according to the <a href="https://www.ft.com/content/ac3c1e2f-c9bc-417e-a686-7170e1bf8533">Financial Times</a>.</li>
<li>That&#8217;s up about 8% from 2023. It&#8217;s also higher than any year since the 828 filings in 2010. Recall how companies were still reeling from the financial crisis at the time.</li>
<li>At least 30 of last year's bankruptcy filers had at least $1 billion in liabilities at the time of filing, the publication noted, citing data from S&amp;P Global Market Intelligence.</li>
<li>Some of the major bankruptcies from 2024 included Party City, Tupperware, Red Lobster, Spirit Airlines and Avon Products.</li>
<li>It&#8217;s worth noting that liability management exercises are becoming increasingly common. These out-of-court sessions are meant to serve as a workaround or alternative to bankruptcy.</li>
<li>Joshua Clark, a senior director at Fitch Ratings, notes that many of the companies that go through those types of ordeals go bankrupt anyway if a debt agreement falls apart.</li>
</ul>
For last week&#8217;s Deal Dispatch, <a href="https://www.benzinga.com/general/health-care/25/01/42793786/deal-dispatch-vera-bradley-party-city-modells-interest">click here</a>.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/real-estate/25/01/42877452/27-million-price-tag-for-late-hasbro-ceos-beverly-hills-oasis">$27 Million Price Tag For Late Hasbro CEO&#8217;s Beverly Hills Oasis</a></li>
</ul>

Deal Dispatch: TD Bank To Sell Charles Schwab Stake? Eyenovia, Smart Share Hit Auction Block

<h1 class="wp-block-heading">New On The Block</h1>
Vera Bradley Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>) <a href="https://www.benzinga.com/24/12/42439021/vera-bradley-reports-30-sales-drop-in-q3-amid-business-model-transition-stock-slips">sales are down</a>. 
The handbag brand&#8217;s largest shareholder, Fund 1 Investments LLC, isn&#8217;t happy about it. A Dec. 30 <a href="https://www.businesswire.com/news/home/20241230656224/en/Fund-1-Sends-Letter-to-Vera-Bradley%E2%80%99s-Board-of-Directors-Highlighting-the-Opportunity-for-Value-Enhancing-Strategic-Alternatives">letter</a> to the board referred to co-founder Barbara Bradley Baekgaard&#8216;s designs as &#8220;iconic&#8221; and &#8220;synonymous with innovation and disruption for decades." 
But after the compliments came the critique: Fund 1 takes issue with Vera Bradley&#8217;s questionable capital allocation, poor operational performance and a failed brand turnaround, all compounded by tough macroeconomic conditions for fashion brands. What's the solution, according to Fund 1? A "strategic alternatives process" to explore selling the company to a larger organization or taking it private.
Also for sale, as of this week:
<ul>
<li>Imagination Technologies Group Limited, a British semiconductor and software design company owned by private equity firm Canyon Bridge Capital Partners, is up for sale. Lazard is shopping it around, according to <a href="https://www.bloomberg.com/news/articles/2025-01-03/chipmaker-imagination-s-owners-tap-lazard-to-search-for-buyer?srnd=phx-deals">Bloomberg</a>. </li>
<li>Skin care startup Minimalist is considering a $350 million deal, TechCrunch <a href="https://techcrunch.com/2025/01/03/hindustan-unilever-minimalist-acquisition/?guccounter=1">reported</a>. On the buy side is Hindustan Unilever Ltd., which recently purchased Oziva and Wellbeing Nutrition. Hindustan Unilever's skincare offerings include Dove and Pond's. Jaipur-based Minimalist reported an 89% revenue growth to $40.8 million in fiscal year 2024.</li>
</ul>
<h1 class="wp-block-heading">Off The Block</h1>
SouthState Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSB#NYSE">SSB</a>) has finalized its $2 billion stock acquisition of Texas-based Independent Bank Group, potentially signaling a wave of regional bank mergers. Key drivers include regional bank stock price growth, lower interest rates improving deposit profitability, and anticipated deregulation under Trump&#8217;s administration.
Hookipa Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOK#NASDAQ">HOOK</a>) is acquiring Poolbeg Pharma in an all-stock deal. Hookipa shareholders retain rights to milestone payments from Gilead&#8217;s hepatitis B partnership and proceeds from the HB-200 program. 
See Also: <a href="https://www.benzinga.com/24/12/42726550/stanley-druckenmiller-loaded-up-on-regional-banks-ahead-of-trumps-election-win">Stanley Druckenmiller Loaded Up On Regional Banks Ahead Of Trump&#8217;s Win</a>
<h1 class="wp-block-heading">Bankruptcy Block</h1>
Mitch Modell, the ex-CEO of the Modell's sporting goods chain, wants to revive bankrupt retailers Party City and Big Lots. He plans to raise $1 billion and keep 33,000 jobs afloat. He also wishes to name his 20-something sons, Matthew and Maxwell, as co-presidents, according to the <a href="https://nypost.com/2024/12/30/business/former-modells-owner-wants-to-save-bankrupt-retailers-party-city-big-lots-our-goal-is-to-save-33k-jobs/">New York Post</a>.
Modell, known for the catchy "Gotta go to Mo's" jingle, had his eureka moment at none other than Mar-a-Lago, where he decided the struggling chains needed a sporting goods flair. His vision includes ditching Big Lots' bulky furniture and sprucing up Party City with sportswear and footwear — because nothing says "Happy Birthday" like a new pair of sneakers.
To keep prices low, Modell plans to tap factories in China, Mexico and India, courtesy of Source One Global. He's also enlisted other former CEOs, such as Larry Meyer (Forever 21) and Demos Parneros (Barnes &amp; Noble) to help evaluate the deal.
<h1 class="wp-block-heading">Notes From The Block</h1>
In 2025, the incoming Trump administration is expected to be friendlier to media conglomerates looking to conduct mergers, compared to the Biden administration. "The overwhelming mood is positive from an M&amp;A perspective," Christopher Vollmer, managing director at MediaLink, told <a href="https://variety.com/2025/biz/news/media-mergers-acquisitions-2025-deals-1236263982/">Variety</a>. "People are looking to kick off M&amp;A activity in the first quarter of 2025."
But people forget that Trump wasn&#8217;t exactly cordial to dealmakers the last time he was in office. The previous&nbsp;Trump&nbsp;administration, from 2016 to 2020, blocked and sued or threatened to block a lot of big deals. 
If you recall:
<ul>
<li>AT&amp;T (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) and Time Warner <a href="https://www.benzinga.com/news/17/11/10748659/at-t-resists-doj-order-to-divest-time-warners-cnn-for-merger-approval">failed to ink a deal</a>. Regulators argued that it could increase prices for consumers and disadvantage rival distributors.</li>
<li>Sinclair Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBGI#NASDAQ">SBGI</a>) and Tribune Media faced resistance due to concerns about consolidation in the broadcast industry. Sinclair <a href="https://www.benzinga.com/m-a/24/11/41805370/jim-cramer-hopes-m-a-to-come-back-bigly-under-trump-administration">paid a hefty fee</a> for whiffing.</li>
<li>Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) and Qualcomm Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>), had they merged, could have affected U.S. national security, a federal <a href="https://www.investors.com/news/technology/broadcom-buyout-of-qualcomm-looking-doubtful-after-federal-probe/">probe</a> showed.</li>
<li>DraftKings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) and FanDuel: A merger of the two largest daily fantasy sports platforms was blocked to preserve competition in the industry.</li>
</ul>
The Department of Justice also mandated divestitures in major transactions. For example:
<ul>
<li>Bristol-Myers Squibb Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) had to divest Celgene&#8217;s Otezla treatment to resolve concerns about reduced competition in the market for psoriasis drugs.</li>
<li>Harris Corp. was required to sell parts of its military communications business to proceed with its merger with L3 Technologies, creating the company L3Harris Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>)</li>
</ul>
These interventions reflected the DOJ's focus on preventing market dominance. Should M&amp;A volume under Trump be comparable to the last four years, deal pros can&#8217;t blame anyone but themselves. 
Now Read:
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/12/42746253/bring-it-on-angry-birds-producer-namit-malhotra-ready-for-cinema-ai-era">&#8216;Bring It On&#8217;: Angry Birds Producer Namit Malhotra Is Ready For The AI Era Of Cinema</a></li>
</ul>

Deal Dispatch: Vera Bradley Is A Mixed Bag, Modell's Ex-CEO Explores Party City

Fund 1 Investments LLC beneficially owns 10.0% of Vera Bradley's outstanding shares.

Shareholder Fund 1 Says Vera Bradley's Brand is Highly Valuable and That Value Is Not Reflected in Share Price; Says Pleased To Hear All Options Are On The Table To Maximize Shareholder Value

WIIM

ABNB

AYRO

CAKE

CAVA

COOK

CTHR

DUOL

FEBO

HTHT

IRBT

PHIN

PTON

SERV

TCOM

TSCO

Shares of companies within the broader consumer discretionary sector are trading lower amid overall market weakness following the Fed's rate decision to cut rates by 25 basis points.

In the latest quarter, 5 analysts provided ratings for Vera Bradley (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>), showcasing a mix of bullish and bearish perspectives.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $5.9, a high estimate of $6.00, and a low estimate of $5.50. This current average represents a 1.67% decrease from the previous average price target of $6.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1733940043_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The standing of Vera Bradley among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Lowers</td>
<td>Buy</td>
<td>$5.50</td>
<td>$6.00</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$6.00</td>
<td>$6.00</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$6.00</td>
<td>$6.00</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$6.00</td>
<td>$6.00</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$6.00</td>
<td>$6.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Vera Bradley. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Vera Bradley compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Vera Bradley's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Vera Bradley's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VRA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Vera Bradley analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Vera Bradley</h2>
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
<h3>Understanding the Numbers: Vera Bradley's Finances</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Challenges: Vera Bradley's revenue growth over 3 months faced difficulties. As of 31 July, 2024, the company experienced a decline of approximately -13.54%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Vera Bradley's net margin excels beyond industry benchmarks, reaching 5.15%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Vera Bradley's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.34%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Vera Bradley's ROA excels beyond industry benchmarks, reaching 1.53%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.31.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Vera Bradley: Insights From 5 Financial Analysts

Small Cap Consumer Research analyst Eric Beder maintains Vera Bradley (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>) with a Buy and lowers the price target from $6 to $5.5.

Small Cap Consumer Research Maintains Buy on Vera Bradley, Lowers Price Target to $5.5

Vera Bradley, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>) shares are trading <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">lower on Wednesday.</a>
The company reported third-quarter net sales of $80.58 million, down <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42434847/vera-bradley-announces-third-quarter-fiscal-year-2025-results" rel="noreferrer noopener">almost 30% year over year.</a>
Jackie Ardrey, Chief Executive Officer, commented, &#8220;The third quarter was extremely challenging as we remained in the early stages of &#8216;Project Restoration&#8217;, our strategic initiative to transform our business model and transition Vera Bradley&#8217;s brand positioning.&#8221;
Vera Bradley Direct segment revenues totaled $52.5 million, a 27.4% decrease year over year. Comparable sales declined 27.2% in the third quarter, with weakness in all direct channels.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/12/42436387/macys-lowers-annual-profit-forecast-amid-accounting-misstep-stock-tumbles" rel="noreferrer noopener">Macy&#8217;s Lowers Annual Profit Forecast Amid Accounting Misstep, Stock Tumbles</a>
Vera Bradley Indirect segment revenues totaled $18.0 million, a 27.9% decrease year over year. The decrease was primarily related to a decline in specialty and key account orders.
Pura Vida segment revenues totaled $10.1 million, a 42.9% decrease from $17.7 million in the prior year&#8217;s third quarter.
The third-quarter consolidated gross profit was $43.6 million, down from $63.0 million a year ago.
Gross margin was 54.1% of net revenues, slightly contracting from 54.8% last year. The decrease in gross profit percentage was due to sales channel mix and a rise in outbound freight costs.
The company reported adjusted earnings per share of 27 cents loss in the quarter under review, compared with 19 cents loss a year ago.
Outlook: Vera Bradley expects FY25 revenues to be $385 million (prior view $410 million), falling short of the $410.02 million estimate, and projects consolidated EPS of approximately $0.25 loss (prior view $0.10) <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">versus the $0.10 estimate.</a>
Price Action: VRA shares are trading lower by 13.9% to $4.63 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42177026" target="_blank" rel="noreferrer noopener">Peacock Pays Up: Macy&#8217;s Thanksgiving Parade Costs Set To Balloon For Content-Hungry NBC</a></li>
</ul>

Earnings

Equities

Guidance

Markets

Movers

General

Vera Bradley Reports 30% Sales Drop In Q3 Amid Business Model Transition, Stock Slips

Vera Bradley (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>) reported its Q3 earnings results on Wednesday, December 11, 2024 at 08:00 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Vera Bradley missed estimated earnings by -550.0%, reporting an EPS of $-0.27 versus an estimate of $0.06.
Revenue was down $34.41 million from the same period last year.
<h3>Earnings History Overview</h3>
Last quarter the company missed on EPS by $0.03 which was followed by a 4.0% increase in the share price the next day.
Here's a look at Vera Bradley's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.16</td>
<td>0</td>
<td>0.14</td>
<td>0.09</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.13</td>
<td>-0.21</td>
<td>0.11</td>
<td>0.19</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>120.66M</td>
<td>90.39M</td>
<td>136.05M</td>
<td>123.09M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>110.82M</td>
<td>80.60M</td>
<td>133.26M</td>
<td>114.99M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Vera Bradley management provided guidance for FY 2025, expecting earnings between $-0.25 and $-0.25 per share.
 Listen to the earnings announcement yourself by <a href="">clicking here</a>. 
To track all earnings releases for Vera Bradley <a href="https://www.benzinga.com/quote/VRA/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Vera Bradley Q3 Earnings

Vera Bradley shares are trading lower after the company reported worse-than-expected Q3 adjusted EPS results and revenue which may not compare to estimates. Additionally, the company issued FY25 revenue guidance below estimates.

Vera Bradley Sees FY25 Revenues Of $385M Vs. $410.02M Estimate, Sees Consolidated Diluted EPS Of Approximately ($0.25)

Buybacks

Vera Bradley Board Approves New $30M Buyback Program Starting After Current $50M Authorization Expires In December 2024

Vera Bradley Q3 Adj EPS $(0.27) Compared With  $(0.19) YoY, Sales $80.58M Compared With $114.987M YoY

<h3>Companies Reporting Before The Bell</h3>
• Vera Bradley (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>) is likely to report quarterly earnings at $0.06 per share on revenue of $98.70 million. 
• REV Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REVG#NYSE">REVG</a>) is expected to report quarterly earnings at $0.49 per share on revenue of $603.33 million. 
• Macy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $4.72 billion. 
• Cognyte Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNT#NASDAQ">CGNT</a>) is expected to report quarterly loss at $0.04 per share on revenue of $87.42 million. 
• Kanzhun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZ#NASDAQ">BZ</a>) is estimated to report quarterly earnings at $0.22 per share on revenue of $266.36 million. 
• Photronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAB#NASDAQ">PLAB</a>) is likely to report quarterly earnings at $0.52 per share on revenue of $218.00 million. 
• Waterdrop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WDH#NYSE">WDH</a>) is estimated to report earnings for its third quarter. 
<h3>Companies Reporting After The Bell</h3>
• Nordson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDSN#NASDAQ">NDSN</a>) is projected to report quarterly earnings at $2.59 per share on revenue of $736.79 million. 
• Oxford Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXM#NYSE">OXM</a>) is estimated to report quarterly earnings at $0.09 per share on revenue of $316.83 million. 
• Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) is estimated to report quarterly earnings at $4.66 per share on revenue of $5.54 billion. 
• Champions Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSBR#NASDAQ">CSBR</a>) is likely to report quarterly earnings at $0.01 per share on revenue of $13.05 million. 
• 17 Education &amp; Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YQ#NASDAQ">YQ</a>) is estimated to report earnings for its third quarter. 
• Kewaunee Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KEQU#NASDAQ">KEQU</a>) is estimated to report earnings for its second quarter. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADBE

CGNT

CSBR

KEQU

NDSN

PLAB

REVG

Earnings Scheduled For December 11, 2024

Vera Bradley (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>) is preparing to release its quarterly earnings on Wednesday, 2024-12-11. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Vera Bradley to report an earnings per share (EPS) of $0.27.
The market awaits Vera Bradley's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Overview of Past Earnings</h3>
The company's EPS missed by $0.03 in the last quarter, leading to a 4.21% increase in the share price on the following day.
Here's a look at Vera Bradley's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.16</td>
<td>0</td>
<td>0.14</td>
<td>0.09</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.13</td>
<td>-0.21</td>
<td>0.11</td>
<td>0.19</td>
</tr>
<tr>
<td>Price Change %</td>
<td>4.0%</td>
<td>-3.0%</td>
<td>4.0%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1733839317_0.png" alt="eps graph" />
<h3>Market Performance of Vera Bradley's Stock</h3>
Shares of Vera Bradley were trading at $5.5 as of December 06. Over the last 52-week period, shares are down 25.17%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<h3>Analyst Observations about Vera Bradley</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Vera Bradley.
The consensus rating for Vera Bradley is Buy, derived from 5 analyst ratings. An average one-year price target of $6.0 implies a potential 9.09% upside.
<h3>Comparing Ratings with Peers</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of Superior Gr of Cos, FIGS and Oxford Industries, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Superior Gr of Cos, with an average 1-year price target of $22.5, suggesting a potential 309.09% upside.</li>
<li>The consensus among analysts is an Neutral trajectory for FIGS, with an average 1-year price target of $6.0, indicating a potential 9.09% upside.</li>
<li>For Oxford Industries, analysts project an Neutral trajectory, with an average 1-year price target of $79.0, indicating a potential 1336.36% upside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
Within the peer analysis summary, vital metrics for Superior Gr of Cos, FIGS and Oxford Industries are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vera Bradley</td>
<td>Buy</td>
<td>-13.54%</td>
<td>$56.36M</td>
<td>2.34%</td>
</tr>
<tr>
<td>Superior Gr of Cos</td>
<td>Buy</td>
<td>9.96%</td>
<td>$60.55M</td>
<td>2.70%</td>
</tr>
<tr>
<td>FIGS</td>
<td>Neutral</td>
<td>-1.51%</td>
<td>$94.03M</td>
<td>-0.42%</td>
</tr>
<tr>
<td>Oxford Industries</td>
<td>Neutral</td>
<td>-0.10%</td>
<td>$265.01M</td>
<td>6.69%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Vera Bradley ranks at the bottom for Revenue Growth and Gross Profit, with negative growth rates and lower profit figures compared to peers. It also has the lowest Return on Equity among the group. Overall, Vera Bradley's performance lags behind its peers in key financial metrics.
<h3>Unveiling the Story Behind Vera Bradley</h3>
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
<h3>A Deep Dive into Vera Bradley's Financials</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Challenges: Vera Bradley's revenue growth over 3 months faced difficulties. As of 31 July, 2024, the company experienced a decline of approximately -13.54%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Vera Bradley's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 5.15%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.34%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Vera Bradley's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.53% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Vera Bradley's debt-to-equity ratio is below the industry average at 0.31, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/VRA/earnings">To track all earnings releases for Vera Bradley visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Examining the Future: Vera Bradley's Earnings Outlook

Small Cap Consumer Research analyst Eric Beder reiterates Vera Bradley (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRA#NASDAQ">VRA</a>) with a Buy and maintains $6 price target.

Small Cap Consumer Research Reiterates Buy on Vera Bradley, Maintains $6 Price Target

Year Of The Dragon: Comprehensive Review Of My 2024 Stock Picks, And Current Ratings

Fund 1 Investments is the largest shareholder of Vera Bradley (VRA) beneficially owning 10.0% of the Company's outstanding shares and having econom...

Vera Bradley's largest stake holder Fund 1 urges strategic alternative for value

Check out this morning's top movers from around Wall Street, compiled by The Fly. HIGHER – Marinus Pharmaceuticals (MRNS) up 43% after Immedica Pha...

Morning Movers: Boeing lower after Jeju Air 737-800 crash in South Korea

Vera Bradley shareholder urges sale of the company

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Boeing (BA) shares were under pressure...

Boeing slips after Jeju Air crash, HashiCorp-IBM draws review: Morning Buzz

Vera Bradley's Rebranding Has Been A Failure, The Stock Is Not Attractive Yet

Vera Bradley announces cost efficiency initiative to save $20M annually

Destination XL Group: Don't Buy The Rumor, Sell The News

Vera Bradley (VRA) announced the appointment of Andrew Meslow, former CEO of L Brands and Bath and Body Works, to the Company's Board of Directors....

Vera Bradley appoints Meslow to board of directors

Vera Bradley ( ($VRA) ) just unveiled an announcement. On February 10, 2025, Vera Bradley announced the appointment of Andrew Meslow, former CEO of...

Vera Bradley Appoints Andrew Meslow to Board of Directors

AAPL

AMTM

AXSM

BBWI

BLDP

COLD

CPRI

CTAS

CTXR

DLMAF

DXLG

FRSX

FVRR

GOLD

HSAI

INTC

KULR

LVMUY

MATW

MHLD

MKTX

MRNS

MSTR

NAMS

NVDA

NVDY

PALL

PFFA

PLCE

PLTM

PPLT

QDTE

QYLD

RCKT

RHHBY

RHHVF

SCHD

SEAT

SOXL

SPAI

SPGI

SPYI

THRM

TIXT

TLRY

TQQQ

TRIP

TTWO

UPWK

VCSA

WKSP

Press Releases

Vera Bradley Launches Limited-Edition Collection in Collaboration With Urban Outfitters

Vera Bradley Announces Second Quarter Fiscal Year 2025 Results

Vera Bradley Foundation for Breast Cancer Raises $1,601,830 for Breast Cancer Research

Vera Bradley Announces Adoption of Limited Duration Shareholder Rights Plan

Management

Vera Bradley Announces Appointment of Ian Bickley to the Board of Directors

Vera Bradley, Inc. Announces Reporting Date for Third Quarter Fiscal Year 2025 Results

Vera Bradley Announces Third Quarter Fiscal Year 2025 Results

Fund 1 Sends Letter to Vera Bradley's Board of Directors Highlighting the Opportunity for Value-Enhancing Strategic Alternatives

Vera Bradley Announces Strategic Cost Efficiency Initiative Providing Approximately $20 Million in Savings to Impact the Upcoming New Fiscal Year 2026

Vera Bradley Continues Board Refreshment with Appointment of Andrew Meslow, Former CEO of Bath and Body Works

Comments

Vera Bradley

매도 수량

Vera Bradley (NASDAQ:VRA) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌